FUNGIZONE (AMPHOTERICIN B) — FDA Approval NDA050341 (BRISTOL MYERS SQUIBB)
FUNGIZONE (AMPHOTERICIN B) — FDA Approval NDA050341 (BRISTOL MYERS SQUIBB) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: FUNGIZONE; Active ingredients: AMPHOTERICIN B; Application number: NDA050341.
| Brand name | FUNGIZONE |
|---|---|
| Active ingredients | AMPHOTERICIN B |
| Application number | NDA050341 |
| Sponsor | BRISTOL MYERS SQUIBB |
| Dosage form | SUSPENSION |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19710602 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →